Hijacking innate immunity to enhance mRNA therapeutics by blocking IFN-P-body-XRN1 axis-mediated degradation

Journal:

Nature Communications

Published:

2026-04-17

DOI:

10.1038/s41467-026-72025-3

Affiliations:

6

Authors:

19

Go to article

Institutions	Authors	Share
Guangzhou Laboratory, China	14.000000 14.000000	0.74
State Key Laboratory of Respiratory Disease (SKLRD), China	2.500000	0.13
MOE Key Laboratory of Molecular Biophysics, HUST, China	1.000000	0.05
University of Macau (UM), China	1.000000	0.05
Huazhong University of Science and Technology (HUST), China	0.500000	0.03

Interested in Oncology and Carcinogenesis?